American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Aug 2015
FK506-binding Protein 10 is a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
Increased abundance and stiffness of the extracellular matrix, in particular collagens, is a hallmark of idiopathic pulmonary fibrosis (IPF). FK506-binding protein 10 (FKBP10) is a collagen chaperone, mutations of which have been indicated in the reduction of extracellular matrix stiffness (e.g., in osteogenesis imperfecta). ⋯ FKBP10 might be a novel drug target for IPF.
-
Am. J. Respir. Crit. Care Med. · Aug 2015
Editorial CommentOutside In: Sequencing the Lung Microbiome.